Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 486

recruiting
3 968
countries
28
conditions
2 103

10 282 trials match your criteria

Hypertension

Not recruiting

Evaluation of the Drug‑Drug Interaction Between Ramipril and Indapamide in Healthy Volunteers

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · Healthy volunteers
  • Substances:Indapamide

Hidradenitis

Not recruiting

Efficacy and Safety Evaluation of Tulisokibart in Moderate to Severe Hidradenitis Suppurativa: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Trial

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart

Obesity

Not recruiting

Orlistat (EMP22) and Drug Combination (acarbose + orlistat) in Healthy Volunteers with Obesity

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · Healthy volunteers
  • Substances:ACARBOSE

Drug level

Not recruiting

Effect of iclepertin on the blood levels of ethinylestradiol and levonorgestrel in healthy premenopausal women

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Ethinylestradiol
Countries:SpainSpain
  • Participants:18–64 years · Healthy volunteers
  • Substances:Paracetamol

COVID-19

Not recruiting

A study of the effects of nirmatrelvir, ritonavir, and rosuvastatin in healthy adult participants

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Nirmatrelvir

Efficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab

Cystic fibrosis

Not recruiting

Evaluation of Safety, Tolerability, and Biodistribution of Inhaled RCT2100 in Cystic Fibrosis: A Phase 1/2 Multicenter Study

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Ivacaftor

Acute myeloid leukaemia+1

Not recruiting

Phase 1b Study of MK-0482 in Adults with Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Mk-0482

Evaluation of HLX10 Combined with Chemotherapy and Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized, Double-Blind Study

InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years

Narcolepsy

Not recruiting

Relative Bioavailability of Pitolisant Tablets in Healthy Male Subjects for Narcolepsy Treatment

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · Healthy volunteers
  • Substances:Pitolisant

Drug level

Not recruiting

Effect of itraconazole on the pharmacokinetics of BI 1584862 in healthy male volunteers

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Itraconazole
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.